AG
FOLD

Artal Group’s Amicus Therapeutics FOLD Stock Holding History

Artal Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,500,000
Closed -$35.5M – 115
2023
Q4 		$35.5M Buy
2,500,000
+2,000,000
+400% +$22.7M 1.18% 14
2023
Q3 		$6.08M Hold
500,000
– – 0.26% 53
2023
Q2 		$6.28M Buy
+500,000
New +$5.93M 0.19% 59
2021
Q1 		– Sell
-1,000,000
Closed -$23.1M – 159
2020
Q4 		$23.1M Hold
1,000,000
– – 0.5% 52
2020
Q3 		$14.1M Hold
1,000,000
– – 0.34% 64
2020
Q2 		$15.1M Hold
1,000,000
– – 0.42% 53
2020
Q1 		$9.24M Buy
1,000,000
+500,000
+100% +$4.75M 0.39% 51
2019
Q4 		$4.87M Hold
500,000
– – 0.19% 72
2019
Q3 		$4.01M Buy
+500,000
New +$5.43M 0.16% 79
2019
Q2 		– Sell
-500,000
Closed -$6.8M – 110
2019
Q1 		$6.8M Hold
500,000
– – 0.28% 66
2018
Q4 		$4.79M Sell
500,000
-500,000
-50% -$5.5M 0.18% 68
2018
Q3 		$12.1M Buy
1,000,000
+500,000
+100% +$6.99M 0.31% 45
2018
Q2 		$7.81M Sell
500,000
-400,000
-44% -$6.05M 0.17% 55
2018
Q1 		$13.5M Sell
900,000
-500,000
-36% -$7.61M 0.17% 40
2017
Q4 		$20.1M Buy
1,400,000
+400,000
+40% +$5.5M 0.3% 27
2017
Q3 		$15.1M Buy
1,000,000
+500,000
+100% +$6.61M 0.26% 28
2017
Q2 		$5.04M Buy
+500,000
New +$4.02M 0.09% 63
2017
Q1 		– Sell
-650,000
Closed -$3.23M – 101
2016
Q4 		$3.23M Hold
650,000
– – 0.07% 68
2016
Q3 		$4.81M Buy
+650,000
New +$4.39M 0.1% 60

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Artal Group's FOLD Position: Q2 2024 in Review

Artal Group sold out of Amicus Therapeutics (FOLD) in Q2 2024, closing a stake of 1,011,776 shares — an estimated $11.9M sold.

Artal Group first reported a position in FOLD in Q2 2016 and held it in 32 quarters. The position peaked at $69.3M in Q4 2021. 258 funds tracked by Wall St. Rank hold FOLD as of Q2 2024.

  • Artal Group reported no remaining Amicus Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Artal Group sold 1,011,776 Amicus Therapeutics shares in Q2 2024, an estimated $11.9M.
  • Artal Group first reported a position in Amicus Therapeutics in Q2 2016 and held it in 32 quarters.
  • Artal Group's Amicus Therapeutics position peaked at $69.3M in Q4 2021.
  • 258 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2024.

Based on Artal Group's 13F filing for Q2 2024, filed 14 Aug 2024.